Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of LY2216684 on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects

NCT01373931 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT01373931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01373931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of LY2216684 on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects
Lead sponsor
Eli Lilly and Company
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2011
Completion date
December 31, 2011
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major